TAK1

N/A

Report date: 2022/08/23 20:00:44

NME

Base Information

Drug NameTAK1

Drug Alias NameTAK1 (X-Rx)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionExtracellular-signal-regulated kinase 5 modulators

TargetsExtracellular-signal-regulated kinase 5

Therapy Area/IndicationsInflammationNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesX-Rx Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesX-Rx Inc

Active IndicationsN/A

Inactive IndicationsInflammationNeoplasms

ATC CodeN/A